Sesame Summit 2026 – application open

Top 10 Healthcare Events and Conferences in 2021 – Selected

If 2020 taught us nothing else it’s that health matters. From stress relief to cognitive function, exercise and a healthy lifestyle had previously proven difficult for most to achieve due to a simple lack of time. Or perceived lack of time.

A global pandemic has changed all of that. And in so much, the Healthcare industry is set to explode in the coming years. If you want in, and you know you do, here are our Top 10 picks for Healthcare Events and Conferences coming up in the first quarter of 2021.

Did we miss some? Let us know about it!

smrs.link/add-event


Top healthcare conferences in January

blank

CES 2021

January 11-14, Virtual Event

#tradeshow #digital #health #wellness #fitness #technology #wearables

CES is the world’s gathering place for all who thrive on the business of consumer technologies. It has served as the proving ground for innovators and breakthrough technologies for 50+ years – the global stage where next-generation innovations are introduced to the marketplace.

Health is a key focus and the digital health summit is a track within the larger conference.

Biotech Showcase 2021

January 11-15, Virtual Event

#conference #biotech #medtech #digital #medicine #pharmaceutical #investors

Biotech Showcase Digital is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives.

This year’s edition offers a seed showcase for startups to present their solutions and meet investors.

Top healthcare conferences in February

blank

HETT Reset 2021

February 8-12, Virtual Event

#conference #healthtech #innovation #digital #health #ecosystem

HETT Reset will reconnect the healthtech and digital health ecosystem at a critical time, with healthcare organisations seeking to lock in the gains and progress made by the sudden and unprecedented transformation in the use of digital health services in response to COVID-19.

From case studies and panel discussions to workshops and live Q&As, the event will cover topics critical to the successful adoption and integration of technology in all healthcare settings across 5-focused days of content and networking opportunities.

Scope Summit 2021

February 2-4, Virtual Event

#conference #clinical #trials #digital #health #data #medical #devices

SCOPE Summit 2021 takes place as a fully virtual event. The program focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations.

This year’s edition covers 12 conference tracks.

DTx West 2021

February 23-25, Virtual Event

#conference #telemedicine #digital #therapeutics #pharmaceutical

DTx West is going virtual. Working with industry leaders, the event provides even more high-quality learning and networking opportunities than usual, through a truly interactive virtual experience. With the recent changes in healthcare, it is now more crucial than ever to accelerate digital therapeutics into the hands of patients.

Top healthcare conferences in March

blank

SXSW 2021

March 16-20, Virtual Event

#festival #creative #health #medtech #DeepTech #innovation

SXSW celebrates the convergence of the interactive, film, and music industries. The conference provides an opportunity for global professionals at every level to participate, network, and advance their careers.

SXSW Health and MedTech Expo is the sub-event of the famed SXSW music, interactive, and film festival.

DIA Europe 2021

March 15-19, Virtual Event

#conference #telemedicine #digital #health  #pharmaceutical #ecosystem

DIA Europe 2021 brings together thousands of innovators from around the globe. It is the must-attend event for all life science professionals working in drug development, from discovery to marketed use.

Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job, your participation will accelerate your growth and your organization’s performance in the development ecosystem.

The Festival of Biologics 2021

March 29 – April 2, Virtual Event

#festival #biologics #pharma #biotech #antibody #innovation

The Festival of Biologics brings together industry leaders from across antibodies, immunotherapy and biosimilars.

There are two parts to the Festival of Biologics: three events covering America Antibody Congress, World Immunotherapy Congress, World Biosimilars Congress and an exhibition featuring solutions for pharma and biotech.

WIRED Health

March 31, London, UK

#conference #healthtech #innovation #DeepTech

WIRED Health explores and maps the future of health, highlighting the thought-provoking disruptors, scientists and practitioners paving paths in how we access, provide and improve patient care.

Since its launch in 2014, WIRED Health continues to connect innovators with influencers and to inspire business decision-makers, entrepreneurs and medical professionals with its editorially-curated programme and interactive Test Lab.

you might also like

Fundraising 43 minutes ago

London-based AI laboratory Ineffable Intelligence has emerged from stealth with a $1.1 billion seed round at a $5.1 billion post-money valuation, the company confirmed on 27 April 2026. The financing is the largest seed round ever raised by a European company and one of the largest first-money-in rounds in the global history of artificial intelligence. The round was co-led by Sequoia Capital and Lightspeed Venture Partners. Participating investors included Nvidia, DST Global, Index Ventures, Google, and the UK Sovereign AI Fund, the British government’s recently established vehicle for backing strategic AI capacity on home soil. A bet on a different path to general intelligence Ineffable Intelligence was founded in 2025 by David Silver, the former Vice President of Reinforcement Learning at Google DeepMind and the principal architect of AlphaGo, AlphaZero and AlphaStar. He is joined by three further DeepMind alumni: Wojciech Czarnecki, Lasse Espeholt and Junhyuk Oh. All four have spent the past decade at the frontier of reinforcement learning research, the discipline behind some of the most consequential demonstrations of machine learning over the past ten years. The company describes its objective as building a “superlearner” — an AI system capable of acquiring knowledge directly from its own experience rather than from human-generated text or imagery. “Our mission is to make first contact with superintelligence,” Silver said in a statement accompanying the launch. “We are creating a superlearner that discovers all knowledge from its own experience, from elementary motor skills through to profound intellectual breakthroughs.” The framing is a deliberate departure from the dominant industry trajectory. Most leading AI laboratories, including OpenAI, Anthropic and Google DeepMind itself, have built large language models trained primarily on the corpus of the internet, then refined that training with human feedback. Ineffable’s wager is that the marginal returns on scaling text-based pretraining are diminishing and that the next leap in capability will come from agents that learn endlessly from the consequences of their own actions, in much the same way AlphaZero learnt the game of Go without studying any human matches. Why $1.1 billion at seed The size of the round is unusual even by the inflated standards of the 2026 AI capital cycle. Two factors appear to explain it. First, frontier reinforcement learning at the scale Ineffable describes is computationally extraordinarily expensive: the company will need to operate vast simulation environments and train very large models against them, an undertaking that consumes capital at a rate closer to physical R&D than to traditional software. Second, the round signals a strategic move by Europe’s investor and policy ecosystems to retain the most ambitious AI researchers on the continent. The presence of the UK Sovereign AI Fund alongside Sequoia, Lightspeed and Nvidia is the clearest expression of that intent. The British government has publicly framed the investment as a bet on breakthrough AI that “can discover new knowledge”, positioning the country as a willing co-investor in domestic frontier laboratories. For Ineffable, the implication is access not only to capital but to compute, regulatory engagement and the still-resilient academic talent base around UCL, Oxford, Cambridge and Imperial. Founder pledge of historic scale Alongside the funding announcement, Silver disclosed that he is committing 100 per cent of any personal proceeds from his Ineffable equity to charity via the Founders Pledge network — described by the organisation as the largest pledge in its history. At the round’s $5.1 billion valuation, that commitment could ultimately exceed several billion dollars if the company succeeds. It is a meaningful gesture in a sector where the reputational stakes around concentrated AI wealth are escalating, and one likely to be referenced in subsequent founder-led commitments. Implications for the European AI landscape Ineffable’s emergence reshapes the European AI map in three concrete ways. It establishes London as the home of the continent’s largest-ever seed-stage company, complicating Paris’s recent narrative of frontier-AI primacy after Mistral’s earlier rounds. It validates a thesis — that reinforcement learning, not transformer scaling, is the next frontier — that has lately been losing capital share to language-model incumbents. And it confirms that the UK government is now willing to act as a balance-sheet co-investor in domestic AI laboratories, a posture much closer to the French model than to the predominantly grant-based regimes elsewhere in Europe. The execution risk is non-trivial. Reinforcement learning at frontier scale has historically required years of careful environment design before producing competitive systems, and Ineffable’s “first contact” framing sets a high bar against which it will be judged. But for now, with a billion dollars on the balance sheet, four of the discipline’s most accomplished researchers in the founding team and a sovereign co-investor at its back, Ineffable Intelligence is the most heavily resourced new entrant in the European AI cycle. Sesamers covers European fundraising rounds across deeptech, fintech and AI. Source: tech.eu.

Fundraising 5 days ago

Belfast's Cloudsmith has raised $72M Series C led by TCV, with Insight Partners participating, to expand its artifact management platform and secure the AI-era software supply chain.

Fundraising 5 days ago

Berlin’s VREY has raised €3.3M seed led by Rubio Impact Ventures to roll out rooftop solar software for Germany’s multi-family buildings.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.